Evidence map›Paper›PMID 40085178›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2025

Efficacy and Safety of Phosphate-Lowering Agents for Adult Patients with CKD Requiring Dialysis: A Network Meta-Analysis.

Masatoshi Nishimoto, Takeshi Hasegawa, Miho Murashima, Hisashi Noma, Hiroki Nishiwaki, Shunsuke Yamada, Aya Mizukami, Hirotaka Saito, Hiroshi Kimura, Masatomo Taniguchi and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Masatoshi NishimotoDepartment of Nephrology, Nara Medical University, Nara, Japan.ORCID 0009-0006-2063-781
Takeshi HasegawaInstitute of Clinical Epidemiology (iCE), Showa Medical University, Tokyo, Japan.ORCID 0000-0003-0420-5583
Miho MurashimaDivision of Nephrology, Department of Internal Medicine, Kindai University Faculty of Medicine, Osaka, Japan.ORCID 0000-0002-2923-0438
Hisashi NomaDepartment of Interdisciplinary Statistical Mathematics, The Institute of Statistical Mathematics, Tokyo, Japan.ORCID 0000-0002-2520-9949
Hiroki NishiwakiDivision of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.ORCID 0000-0001-7365-7685
Shunsuke YamadaDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Aya MizukamiDivision of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.ORCID 0009-0001-6429-0241
Hirotaka SaitoDepartment of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan.
Hiroshi KimuraDepartment of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan.ORCID 0000-0002-2331-215
Masatomo TaniguchiFukuoka Renal Clinic, Fukuoka, Japan.
Takayuki HamanoDepartment of Nephrology, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan.ORCID 0000-0002-2100-9106
Masafumi FukagawaDivision of Nephrology, Endocrinology, and Metabolism, Tokai University School of Medicine, Kanagawa, Japan.

Funding

Japan Society for the Promotion of Science London 22H03554, 19K03092, and 24K06239
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ESKDphosphate binders

Identifiers

PMID40085178
PMCPMC12097192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.